Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galectins | 3 | 2022 | 278 | 1.950 |
Why?
|
| Sialyltransferases | 6 | 2023 | 75 | 1.210 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2022 | 165 | 0.810 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2022 | 242 | 0.720 |
Why?
|
| Galectin 1 | 1 | 2019 | 127 | 0.640 |
Why?
|
| Immunomodulation | 1 | 2020 | 540 | 0.560 |
Why?
|
| Blood Proteins | 1 | 2022 | 1151 | 0.550 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2017 | 636 | 0.460 |
Why?
|
| Deoxycytidine | 1 | 2017 | 843 | 0.440 |
Why?
|
| Firearms | 1 | 2019 | 615 | 0.400 |
Why?
|
| Pancreatic Neoplasms | 4 | 2023 | 5261 | 0.330 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4414 | 0.310 |
Why?
|
| DNA Damage | 1 | 2017 | 2387 | 0.300 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 4671 | 0.290 |
Why?
|
| Protein Transport | 2 | 2022 | 1960 | 0.250 |
Why?
|
| Ligands | 2 | 2022 | 3266 | 0.250 |
Why?
|
| Antigens, CD | 4 | 2023 | 3898 | 0.210 |
Why?
|
| Neoplastic Stem Cells | 3 | 2020 | 1341 | 0.200 |
Why?
|
| Glycosyltransferases | 1 | 2021 | 114 | 0.180 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2024 | 314 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2023 | 23112 | 0.170 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 17 | 0.150 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2017 | 32 | 0.150 |
Why?
|
| Comet Assay | 1 | 2017 | 73 | 0.150 |
Why?
|
| Neuraminidase | 1 | 2017 | 201 | 0.150 |
Why?
|
| Endothelium | 1 | 2019 | 760 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2020 | 1853 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 725 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 1173 | 0.130 |
Why?
|
| Immunoblotting | 1 | 2017 | 1649 | 0.120 |
Why?
|
| Organoids | 1 | 2020 | 711 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2020 | 3089 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2019 | 835 | 0.110 |
Why?
|
| Cell Communication | 1 | 2020 | 1628 | 0.110 |
Why?
|
| Ovarian Neoplasms | 2 | 2023 | 4845 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 1672 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 1362 | 0.090 |
Why?
|
| Glioblastoma | 2 | 2022 | 3453 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 5413 | 0.090 |
Why?
|
| Protein Binding | 1 | 2022 | 9278 | 0.080 |
Why?
|
| Homeostasis | 1 | 2020 | 3260 | 0.080 |
Why?
|
| Cell Movement | 1 | 2020 | 5162 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3657 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 16657 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3607 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 2 | 2020 | 143 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 2793 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 11036 | 0.070 |
Why?
|
| Humans | 13 | 2024 | 746044 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 5688 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8355 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2019 | 4594 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11384 | 0.050 |
Why?
|
| Mice | 5 | 2023 | 80087 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5159 | 0.050 |
Why?
|
| Metaplasia | 1 | 2023 | 319 | 0.050 |
Why?
|
| Melanoma | 1 | 2021 | 5569 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2017 | 12741 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10018 | 0.050 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2022 | 177 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2022 | 186 | 0.050 |
Why?
|
| N-Acetylhexosaminyltransferases | 1 | 2021 | 5 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 9521 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 8832 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 6137 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13538 | 0.050 |
Why?
|
| Animals | 5 | 2023 | 166331 | 0.040 |
Why?
|
| Pancreas | 1 | 2023 | 1674 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2016 | 12039 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 2070 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 2054 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 1078 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3584 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1809 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2620 | 0.020 |
Why?
|
| Transfection | 1 | 2019 | 5786 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4816 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 2918 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3526 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3694 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15631 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9441 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9170 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12632 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11064 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10300 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 9421 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 17834 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16245 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21673 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 21529 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29068 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11539 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 40503 | 0.010 |
Why?
|
| Female | 2 | 2023 | 382109 | 0.010 |
Why?
|
Concepts
(95)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_